164 completed. 164 Phase 2, 24 Phase 3, 17 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 164 | Completed 164 |
| Phase 3 | 24 | Completed 24 |
| Phase 1 | 17 | Completed 17 |
Follow Exercise: new trials by email Literature Review of Exercise trials Research Report on Exercise
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Impact of LLL and Aerobic Exercise on Peripheral Arterial Outcomes in Patients With Type 2 Diabetes aerobic exercise + low-level laser therapy, Aerobic exercise - Type 2 Diabetes Mellitus (T2DM) | Phase 2 | Completed | Nouran Hesham Slama Younis | 40 | 2025-02-20 | 2025-08-19 |
| Fitness After Stroke Trial Exercise MICT, Exercise HIIT - Stroke, Stroke, Ischemic | Phase 2 | Completed | University of Kansas Medical Center | 59 | 2023-07-03 | 2026-01-06 |
| The Lived Experiences Measured Using Rings Pilot Study Moodlifters, Physical Activity, Nature Experiences - Depression, Stress | Phase 2 | Completed | University of Vermont | 188 | 2022-12-01 | 2025-04-17 |
| Effect of Aerobic Training and Ginkgo Biloba on Lipids Levels in HIV-positive Patients Undergoing Antiretroviral Treatment Aerobic exercise + Ginkgo Biloba Extract, Aerobic exercise + Calcined magnesia (placebo), Aerobic exercise + Atorvastatin - Human Immunodeficiency Virus | Phase 2 / Phase 3 | Completed | University of Guadalajara | 28 | 2022-05-01 | 2024-05-08 |
| Slow Age: Interventions to Slow Aging in Humans Exercise, Time restricted feeding, Nicotinamide riboside - Aging | Phase 2 | Completed | University of Copenhagen | 80 | 2022-05-01 | 2023-04-25 |
| Feasibility of Home-based Exercise Program for Adults With Cystic Fibrosis Xenon MRI - Cystic Fibrosis | Phase 2 | Completed | University of Kansas Medical Center | 21 | 2022-03-15 | 2025-06-12 |
| The Acute Effects of Exercise and Caffeine on Working Memory During Acute Caffeine Deprivation Acute Exercise, Caffeine Powder - Acute Exercise, Caffeine Withdrawal | Phase 2 / Phase 3 | Completed | Western University, Canada | 7 | 2022-01-10 | 2024-03-04 |
| Exercise Plus Duloxetine for Knee Osteoarthritis Aerobic exercise, Duloxetine - Knee Osteoarthritis, Depression | Phase 2 | Completed | University of Maryland, Baltimore | 43 | 2021-10-07 | 2026-10-29 |
| Corticosteroid Effects on Asymptomatic Gadolinium-enhancing Lesions in Multiple Sclerosis Methylprednisolone succinate, Normal saline - Multiple Sclerosis, Relapsing-Remitting, Magnetic Resonance Imaging | Phase 2 | Completed | Mazandaran University of Medical Sciences | 102 | 2021-05-22 | 2025-07-15 |
| Type 2 Diabetes Mellitus Prevention Ukraine Physical activity, Macronutrient modification - Impaired Fasting Glucose, Impaired Glucose Tolerance | Phase 2 | Completed | Komisarenko Institute of Endocrinology and Metobolism | 30 | 2020-02-20 | 2022-08-26 |
| A Study to Evaluate LB1148 for Return of Gastrointestinal Function and Adhesions in Subjects Undergoing Bowel Resection LB1148, Placebo - Ileus, Post-Operative Adhesions | Phase 2 | Completed | Palisade Bio | 112 | 2019-10-01 | 2024-06-21 |
| Gut Imaging for Function & Transit in Cystic Fibrosis Study 2 Tezacaftor/Ivacaftor + Ivacaftor, Placebo oral tablet - Cystic Fibrosis | Phase 2 | Completed | Nottingham University Hospitals NHS Trust | 12 | 2019-09-03 | 2023-05-24 |
| Saline Injections vs Education and Exercise in Knee Osteoarthritis GLA:D, Intra-articular saline injection - Osteoarthritis, Knee | Phase 2 | Completed | Marius Henriksen | 206 | 2019-08-05 | 2020-12-22 |
| ACES - ACE Inhibitors Combined With Exercise for Seniors With Hypertension Aerobic exercise, Perindopril, Losartan - Hypertension, Aging | Phase 2 | Completed | University of Alabama at Birmingham | 223 | 2018-05-29 | 2025-07-22 |
| Physical Activity Monitored by Fitbit Charge 2 in Improving Quality of Life in Participants With Recurrent Ovarian, Primary Peritoneal, or Fallopian Tube Cancer Laboratory Biomarker Analysis, Monitoring Device, Physical Activity - Fallopian Tube Endometrioid Tumor, Fallopian Tube Mucinous Neoplasm | Phase 2 | Completed | Roswell Park Cancer Institute | 9 | 2017-06-27 | 2021-09-02 |
| A Trial of a Botanical Drug (EISO) for Treatment of Mild-to-Moderate Plaque Psoriasis SAN021 Serum, SAN021 Placebo - Plaque Psoriasis | Phase 2 | Completed | Santalis Pharmaceuticals, Inc. | 69 | 2017-05-17 | 2019-05-29 |
| Prevention of Comorbid Depression and Obesity in Attention-deficit/ Hyperactivity Disorder Bright light therapy, Physical exercise - Attention-Deficit / Hyperactivity Disorder, Depression | Phase 2 | Completed | Goethe University | 207 | 2017-03-13 | 2020-10-19 |
| Omega-3 Fatty Acids and Exercise on Mobility and Cognition in Older Women Efamol Active 50+, Aerobic exercise, Placebo multinutrient - Aging, Cognitive Decline | Phase 2 | Completed | Bournemouth University | 60 | 2017-02-26 | 2019-01-16 |
| Efficacy Study in Patients With Acne Vulgaris. ADPS topical product, Placebo Control - Acne Vulgaris | Phase 2 | Completed | Sun Pharmaceutical Industries, Inc. | 294 | 2016-10-03 | 2018-10-18 |
| An Open Label, Safety Study to Assess the Potential for Adrenal Suppression DSXS topical - Plaque Psoriasis | Phase 2 | Completed | Sun Pharmaceutical Industries, Inc. | 16 | 2016-09-02 | 2018-12-06 |
Showing 20 of 164. Sign in to see all of them.
Motor Activity (61) · Obesity (17) · Cardiovascular Diseases (13) · Breast Neoplasms (9) · Insulin Resistance (9) · Heart Diseases (7) · Diabetes Mellitus (6) · Diabetes Mellitus, Type 2 (6) · Hypertension (6) · Depression (5) · Fibromyalgia (5) · Kidney Failure, Chronic (5) · Metabolic Syndrome (5) · Weight Loss (5) · Dermatitis, Atopic (4)
Sun Pharmaceutical Industries, Inc. (9) · National Heart, Lung, and Blood Institute (NHLBI) (6) · Duke University (5) · National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (4) · Vanderbilt University (4) · Institut de Recherches Cliniques de Montreal (3) · Kaiser Permanente (3) · Northwestern Health Sciences University (3) · Stanford University (3) · University Health Network, Toronto (3) · University of Wisconsin, Madison (3) · AHS Cancer Control Alberta (2) · Bristol-Myers Squibb (2) · Brown University (2) · Butler Hospital (2)
United States (91) · Canada (18) · Denmark (5) · Germany (5) · Spain (5) · United Kingdom (5) · Norway (4) · Mexico (3) · Netherlands (3) · Brazil (2) · Sweden (2) · Australia (1) · China (1) · Egypt (1) · France (1)
Alp Ikizler, MD (4) · Shabbir MH Alibhai, MD, MSc (3) · Eileen G. Collins, PhD RN (2) · Gert Bronfort, DC, PhD (2) · Harry Prapavessis, PhD (2) · Thomas Buford, PhD (2) · Adam G Tsai, MD, MSCE (1) · Alan Smyth, Prof (1) · Amy Kossert, MHK (1) · Ana Abrantes, PhD (1) · Ana M Abrantes, Ph.D. (1) · Anders Hovland, PsyD (1) · Andrea S Sousa, PhD (1)
PMID 25091629, PMID 29976553, PMID 32390133, PMID 33210751, PMID 35018639, PMID 11739090, PMID 12525233, PMID 14655916, PMID 14678952, PMID 15087413, PMID 15159321, PMID 15175588, PMID 15213282, PMID 15229337, PMID 15243275, PMID 15247119, PMID 15247126, PMID 15298949, PMID 15539040, PMID 15556826, PMID 15585547, PMID 15681521, PMID 15824183, PMID 15833948, PMID 15943960, PMID 16232102, PMID 16531889, PMID 16826020, PMID 16909130, PMID 16985018, PMID 17020620, PMID 17071161, PMID 17087620, PMID 17167156, PMID 17287149, PMID 17507612, PMID 17557987, PMID 17855695, PMID 17940108, PMID 18006923, PMID 18155998, PMID 18202351, PMID 18202581, PMID 18403448, PMID 18501061, PMID 18821656, PMID 18923311, PMID 19130989, PMID 19592624, PMID 19928484
R01DK045604 (3), 2009 (1), 2015 (1), K01AG064041 (1), K07CA168886 (1), K23AT001879 (1), K23DA019950 (1), K24DK065018 (1), R01AG018198 (1), R01AR044064 (1), R01AR044724 (1), R01AR045310 (1), R01AT004313 (1), R01AT006970 (1), R01CA134903 (1)